These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1023 related items for PubMed ID: 9398141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients.
    Tsuchiya K, Okano H, Teramura M, Iwamoto Y, Yamashita N, Suda A, Shimada K, Nihei H, Ando M.
    Clin Nephrol; 2003 Feb; 59(2):115-23. PubMed ID: 12608554
    [Abstract] [Full Text] [Related]

  • 3. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
    Chuang CL, Liu RS, Wei YH, Huang TP, Tarng DC.
    Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894
    [Abstract] [Full Text] [Related]

  • 4. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients.
    Fishbane S, Galgano C, Langley RC, Canfield W, Maesaka JK.
    Kidney Int; 1997 Jul; 52(1):217-22. PubMed ID: 9211366
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy.
    Bhandari S, Norfolk D, Brownjohn A, Turney J.
    Am J Kidney Dis; 1997 Dec; 30(6):814-21. PubMed ID: 9398126
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of iron deficiency testing strategies in hemodialysis patients.
    Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J.
    Kidney Int; 2001 Dec; 60(6):2406-11. PubMed ID: 11737617
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients.
    Kim JM, Ihm CH, Kim HJ.
    Int J Lab Hematol; 2008 Feb; 30(1):46-52. PubMed ID: 18190467
    [Abstract] [Full Text] [Related]

  • 8. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC, Tsai TJ, Chen YM, Lin SL, Hsieh BS.
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [Abstract] [Full Text] [Related]

  • 9. The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study.
    Ogawa C, Tsuchiya K, Tomosugi N, Shimada K, Kanda F, Maeda K.
    Hematology; 2020 Dec; 25(1):71-78. PubMed ID: 32009585
    [Abstract] [Full Text] [Related]

  • 10. Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content.
    Mitsuiki K, Harada A, Miyata Y.
    Clin Exp Nephrol; 2003 Mar; 7(1):52-7. PubMed ID: 14586744
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of reticulocyte hemoglobin content, percentage of hypochromic red blood cells, and ratio of serum transferrin receptor level/serum iron level as markers of iron-deficiency erythropoiesis in patients undergoing hemodialysis].
    Hasegawa M, Kawamura N, Koide S, Murase M, Asano S, Toba T, Kushimoto H, Murakami K, Tomita M, Hasegawa H, Shikano M, Mizuno M, Funahashi N, Kawashima S, Sugiyama S.
    Nihon Jinzo Gakkai Shi; 2002 Mar; 44(5):453-63. PubMed ID: 12216478
    [Abstract] [Full Text] [Related]

  • 12. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.
    Kaneko Y, Miyazaki S, Hirasawa Y, Gejyo F, Suzuki M.
    Kidney Int; 2003 Mar; 63(3):1086-93. PubMed ID: 12631092
    [Abstract] [Full Text] [Related]

  • 13. Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients.
    Deira J, González-Sanchidrián S, Polanco S, Cebrián C, Jiménez M, Marín J, Gómez-Martino JR, Fernández-Pereira L, Tabernero J.
    Ren Fail; 2016 Aug; 38(7):1076-81. PubMed ID: 27197731
    [Abstract] [Full Text] [Related]

  • 14. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients.
    Tsuchiya K, Saito M, Okano-Sugiyama H, Nihei H, Ando M, Teramura M, Iwamoto YS, Shimada K, Akiba T.
    Ren Fail; 2005 Aug; 27(1):59-65. PubMed ID: 15717636
    [Abstract] [Full Text] [Related]

  • 15. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M, Salopek S, Möller M, Schliesser J, Klooker P, Reddig J, Gansert U, Brass H.
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [Abstract] [Full Text] [Related]

  • 16. [Measuring the content of reticulocyte hemoglobin (CHr) in predialysis chronic renal failure (CRF) patients].
    Saito M, Tsuchiya K, Ando M, Akiba T, Nihei H.
    Nihon Jinzo Gakkai Shi; 2003 Jul; 45(5):430-8. PubMed ID: 14509218
    [Abstract] [Full Text] [Related]

  • 17. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 18. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M, Munaretto G, Spinello M, Rebeschini M, Amici G, Gallieni M, Piccoli A.
    J Nephrol; 2005 Jun; 18(1):72-9. PubMed ID: 15772926
    [Abstract] [Full Text] [Related]

  • 19. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
    Ahluwalia N, Skikne BS, Savin V, Chonko A.
    Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
    [Abstract] [Full Text] [Related]

  • 20. The Role of Reticulocyte Hemoglobin Content for Diagnosis of Iron Deficiency and Iron Deficiency Anemia, and Monitoring of Iron Therapy: a Literature Review.
    Gelaw Y, Woldu B, Melku M.
    Clin Lab; 2019 Dec 01; 65(12):. PubMed ID: 31850722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.